Description
ADAMTS13 destabilizes thrombi in a mouse model of thrombotic focal cerebral ischemia
- You cannot add another "Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma" to your cart. View cart
Article: ADAMTS13 destabilizes thrombi in a mouse model of thrombotic focal cerebral ischemia
€3.03
Related products
-
Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma
€3.03 Add to cart -
Article: Highlights in breast cancer
€3.03 Add to cart -
Article: Highlights in squamous cell carcinoma of the head and neck
€3.03 Add to cart -
Article: Highlights in gynaecological cancers
€3.03 Add to cart
Reviews
There are no reviews yet.